Phosphodiesterase-5 Inhibitor Use in Robot Assisted Radical Prostatectomy Patients Is Associated with Reduced Risk of Death: A Propensity Score Matched Analysis of 1,058 Patients

PURPOSE: We investigated whether the use of a phosphodiesterase-5 inhibitor (PDE5i) after robot assited radical prostatectomy has a survival benefit over non-use patients because there are controversial results on the association between PDE5i use and survival outcomes for prostate cancer patients i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jongsoo, Kim, Hye Rim, Heo, Ji Eun, Jang, Won Sik, Lee, Kwang Suk, Kang, Sung Ku, Han, Hyunho, Choi, Young Deuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Sexual Medicine and Andrology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523119/
https://www.ncbi.nlm.nih.gov/pubmed/36649919
http://dx.doi.org/10.5534/wjmh.220063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523119/
https://www.ncbi.nlm.nih.gov/pubmed/36649919
http://dx.doi.org/10.5534/wjmh.220063

Ejemplares similares